QA: CHINOOK THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2023_CHINOOK_THERAPEUTICS_INC.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001435049')"}

Graph

Absolute values for 0001435049, CHINOOK THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 385,592,000
1 IntangibleAssetsNetIncludingGoodwill 24,404,000
2 PropertyPlantAndEquipmentNet 16,908,000
3 remainder_Assets 147,180,000
4 LiabilitiesCurrent 50,835,000
5 LiabilitiesNoncurrent 34,494,000
6 remainder_Liabilities 46,814,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,291,000
9 ResearchAndDevelopmentExpense 141,211,000
10 remainder_Expenses 18,050,000
11 remainder_Revenues 6,128,000
12 remainder_NetIncome 1,559,000
13 remainder_ComprehensiveNetIncome -3,109,000
  yvar yval
0 Assets 574,084,000
1 Liabilities 132,143,000
2 Expenses 195,552,000
3 Revenues 6,128,000
4 StockholdersEquity 441,941,000
5 NetIncome -187,865,000
6 ComprehensiveNetIncome -189,419,500
7 BaseVar 456,287,500
8 EconomicCapitalRatio 1.62

Edgar->Model Mapping

Feature Distribution

Change over Time